Leading Pharma recalls

Leading Pharma has 3 recalls on record with the FDA and USDA, the earliest in 2017 and the latest reported on 29 Apr 2026. 1 is still ongoing. 1 was reported in the last 12 months. The most frequent reason is nitrosamine impurity.

Total recalls3since 2017

Last 12 months1reported

Class I00% of total

Ongoing1latest 29 Apr 2026

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 1Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 2 67%Class III 1 33%

Why leading pharma is recalled

Product types

Anxiety & Sleep Medication133%

Brands

By year

2026133%
2022133%
2017133%

Ongoing leading pharma recalls

1 active

Reported	Class	Recall	Company	Reason	Where
29 Apr 2026Drug	CLASS II	Furosemide Tablets, USP, 80 mg recalled by Leading PharmaFurosemide	Leading Pharma	Nitrosamine Impurity	Nationwide

All leading pharma recalls, newest first

3 total

Reported	Class	Recall	Company	Reason	Where
29 Apr 2026Drug	CLASS II	Furosemide Tablets, USP, 80 mg recalled by Leading PharmaFurosemide	Leading Pharma	Nitrosamine Impurity	Nationwide
5 Oct 2022Drug	CLASS III	ClomiPRAMINE Hydrochloride Capsules, USP 25mg recalled by Leading PharmaClomipramine Hydrochloride	Leading Pharma	Potency & Assay	Nationwide
29 Nov 2017Drug	CLASS II	Lorazepam Tablets, USP CIV, 5 mg recalled by Leading PharmaLorazepam	Leading Pharma	Other	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.